Rolf K. Hoffmann
Fortune : 1 M $ au 31/05/2026
Fortune : 1 M $ au 31/05/2026
Rolf K.
Hoffmann currently works at BPC Plasma, Inc., as Chairman, Sun Pharmaceutical Industries Ltd., as Independent Director from 2023, IDT Biologika GmbH, as Director, World Anti-Doping Agency, as Director, NavBio AG, as Director, Trizell Ltd., as Director, Idt Biologika Corp., as Director, Semdor Pharma Group GmbH, as Director, Dessau-Rosslau, as Director, and Genmab A, as Independent Director from 2017.
Mr. Hoffmann also formerly worked at Lilly Deutschland GmbH, as Chief Executive Officer-Global Marketing, Biotest AG, as Chairman-Supervisory Board from 2017 to 2022, EUSA Pharma, Inc., as Director, Trigemina, Inc., as Director, Copenhagen Capital A, as Director, Paratek Pharmaceuticals, Inc., as Independent Director from 2018 to 2023, Recordati UK Ltd., as Director, Shield Therapeutics Plc, as Independent Non-Executive Director from 2018 to 2021, Ferring Holding, Inc., as Director, Trizell Holding SA, as Director, Amgen, Inc., as Vice President-US Commercial Operations from 2012 to 2016, Eli Lilly & Co., as General Manager-Germany in 2004, STADA Arzneimittel AG, as Member-Supervisory Board from 2016 to 2017, and Amgen (Europe) GmbH, as Senior VP-International Commercial Operations.
Mr. Hoffmann received his graduate degree from Universität zu Köln, Masters Business Admin degree from The University of North Carolina at Chapel Hill, and graduate degree from Deutsche Sporthochschule Köln.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
GENMAB A/S 0,01% | 17/02/2026 | 3 779 ( 0,01% ) | 1 M $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| GENMAB A/S | Directeur/Membre du Conseil | 01/01/2017 |
| SUN PHARMACEUTICAL INDUSTRIES LTD. | Directeur/Membre du Conseil | 15/06/2023 |
Dessau-Rosslau
Dessau-Rosslau Real Estate DevelopmentFinance Operators of Nonresidential Buildings | Directeur/Membre du Conseil | - |
Semdor Pharma Group GmbH
Semdor Pharma Group GmbH Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceuticals | Directeur/Membre du Conseil | - |
Idt Biologika Corp.
Idt Biologika Corp. Pharmaceuticals: OtherHealth Technology Idt Biologika Corp. is a contract development and manufacturing organization (CDMO) specializing in vaccines, viral vectors for gene and immune therapeutics, cell and gene therapy products, and biologics including monoclonal antibodies, proteins, enzymes, biosimilars, and small molecules. The private company is based in Rockville. The American company provides end-to-end services such as process development, drug substance manufacturing, aseptic liquid filling and lyophilization, secondary packaging with serialization and track-and-trace, quality control, analytics, and regulatory support. Its facilities feature GMP-compliant aseptic fill-finish lines, automated visual inspection, and expanded packaging capabilities for clinical and commercial supply. Idt Biologika offers process development expertise across upstream and downstream technologies, supports both adherent and suspension cell cultures, and provides proprietary cell lines and cell banks. Analytical development services include viral, microbiological, molecular, biological, and chemical-physical testing using advanced technologies. The company supports pharmaceutical and biotech clients from early clinical phases through commercial manufacturing, including pandemic preparedness and complex product types such as mRNA vaccines, oncolytic viruses, and virus-like particles. | Directeur/Membre du Conseil | - |
Trizell Ltd.
Trizell Ltd. BiotechnologyHealth Technology Develops biotechnology products | Directeur/Membre du Conseil | - |
BPC Plasma, Inc.
BPC Plasma, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Président | - |
World Anti-Doping Agency
World Anti-Doping Agency Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit organization that specializes in scientific research, education and development of anti-doping capacities & monitoring world anti doping code | Directeur/Membre du Conseil | - |
NavBio AG
NavBio AG Miscellaneous Commercial ServicesCommercial Services Provides business and management consulting services | Directeur/Membre du Conseil | - |
| ░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░ ░░░░░ ░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 27 |
|---|---|
Amgen, Inc.
Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Eli Lilly & Co.
Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
EUSA Pharma, Inc.
EUSA Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and researches pharmaceutical products | Health Technology |
Trigemina, Inc.
Trigemina, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to control pain and migraine headache | Health Technology |
Copenhagen Capital A/S
Copenhagen Capital A/S Real Estate DevelopmentFinance Provides residential and commercial real estate rental and leasing services | Finance |
STADA Arzneimittel AG
STADA Arzneimittel AG Pharmaceuticals: GenericHealth Technology Manufactures generic drugs and pharmaceuticals | Health Technology |
Sun Pharmaceutical Industries Ltd.
Sun Pharmaceutical Industries Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical ingredients | Health Technology |
Genmab A/S
Genmab A/S BiotechnologyHealth Technology Operates as a biotechnology company for improving the lives of people with cancer and serious diseases through antibody medicines | Health Technology |
Biotest AG
Biotest AG Pharmaceuticals: OtherHealth Technology Develops, manufactures and distributes therapy medicinal products | Health Technology |
Universität zu Köln
Universität zu Köln Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of North Carolina at Chapel Hill
The University of North Carolina at Chapel Hill Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BPC Plasma, Inc.
BPC Plasma, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Lilly Deutschland GmbH
Lilly Deutschland GmbH Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Amgen (Europe) GmbH
Amgen (Europe) GmbH BiotechnologyHealth Technology Manufactures human therapeutics | Health Technology |
IDT Biologika GmbH
IDT Biologika GmbH BiotechnologyHealth Technology Develops and manufactures viral vaccines & vectors | Health Technology |
World Anti-Doping Agency
World Anti-Doping Agency Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit organization that specializes in scientific research, education and development of anti-doping capacities & monitoring world anti doping code | Commercial Services |
Deutsche Sporthochschule Köln
Deutsche Sporthochschule Köln Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Paratek Pharmaceuticals, Inc.
Paratek Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
EUSA Pharma (UK) Ltd.
EUSA Pharma (UK) Ltd. Medical DistributorsDistribution Services Supplies medicines and medical devices | Distribution Services |
Shield Therapeutics Plc
Shield Therapeutics Plc Pharmaceuticals: MajorHealth Technology Develops and commercializes late stage pharmaceutical products | Health Technology |
Ferring Holding, Inc.
Ferring Holding, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceuticals | Health Technology |
NavBio AG
NavBio AG Miscellaneous Commercial ServicesCommercial Services Provides business and management consulting services | Commercial Services |
Trizell Ltd.
Trizell Ltd. BiotechnologyHealth Technology Develops biotechnology products | Health Technology |
Idt Biologika Corp.
Idt Biologika Corp. Pharmaceuticals: OtherHealth Technology Idt Biologika Corp. is a contract development and manufacturing organization (CDMO) specializing in vaccines, viral vectors for gene and immune therapeutics, cell and gene therapy products, and biologics including monoclonal antibodies, proteins, enzymes, biosimilars, and small molecules. The private company is based in Rockville. The American company provides end-to-end services such as process development, drug substance manufacturing, aseptic liquid filling and lyophilization, secondary packaging with serialization and track-and-trace, quality control, analytics, and regulatory support. Its facilities feature GMP-compliant aseptic fill-finish lines, automated visual inspection, and expanded packaging capabilities for clinical and commercial supply. Idt Biologika offers process development expertise across upstream and downstream technologies, supports both adherent and suspension cell cultures, and provides proprietary cell lines and cell banks. Analytical development services include viral, microbiological, molecular, biological, and chemical-physical testing using advanced technologies. The company supports pharmaceutical and biotech clients from early clinical phases through commercial manufacturing, including pandemic preparedness and complex product types such as mRNA vaccines, oncolytic viruses, and virus-like particles. | Health Technology |
Semdor Pharma Group GmbH
Semdor Pharma Group GmbH Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceuticals | Health Technology |
Trizell Holding SA | |
Dessau-Rosslau
Dessau-Rosslau Real Estate DevelopmentFinance Operators of Nonresidential Buildings | Finance |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national